#401 Updates in Addiction Medicine - SGIM 2023
The Curbsiders Internal Medicine Podcast
00:00
The Rise of Telehealth Services for Opioid Use Disorder
At the beginning of our horrific pandemic and March of 2020, certain rule changes were offered by the DEA to allow the initiation of buprenorphine for care of opioid use disorder. I think that at the time it was just understood that we need to continue access to treatment. It likely also allowed more people to consider ways to access treatment when there's nobody nearby who can prescribe bu prenorphine. There have been some real uncertainty as to what the rules should be going forward. The DEA is still considering that issue.
Transcript
Play full episode
